| Initial public offering of 28,875,000 equity shares of face value of Re. 1 each (The "equity shares") of Eris Lifesciences Limited (The "company" or The "Issuer") for cash at a price of Rs. 603 per equity share (The "Offer Price") aggregating to Rs. 1741.16 crores (The "offer") through an offer for sale of up to 22,344,000 equity shares aggregating to Rs. 1347.34 crores by Botticelli (The "Investor selling shareholder"), up to 687,500 equity shares aggregating to Rs. 41.46 crores by Mr. Amit Indubhushan Bakshi, 687,500 equity shares aggregating to Rs. 41.46 crores by Mr. Himanshu Jayantbhai Shah, 1,031,167 equity shares aggregating to Rs. 62.18 crores by Mr. Inderjeet Singh Negi, 1,031,166 equity shares aggregating to Rs. 62.18 crores by Mr. Rajendrakumar Rambhai patel, 1,031,167 equity shares aggregating to Rs. 62.18 crores by Mr. Kaushal kamlesh Shah, (together the "promoter selling shareholders" 1,375,000 equity shares aggregating to Rs. 82.91 crores by Mr. Bhikhabhai Chimanlal Shah, 687,500 equity shares aggregating to Rs. 41.46 crores by Mr. Hetal Rasiklal shah, (collectively The "Offer selling shareholders" together with the investors selling shareholders and the promoters selling shareholders, the "selling shareholders"). The offer includes a reservation of 150,000 equity shares aggregating to Rs. 8.15 crores, for subscription by eligible employees
(as defined hereinafter) (The "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "net offer", aggregating up to 28,725,000 equity shares. The offer and the net offer shall constitute 21% and 20.89%, respectively of the post-offer paid-up equity share capital of the company.
Offer price: Rs.603 per equity share of face value of Re.1 each.
The offer price is 603 times of the face value. |